Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication May 22, 2024
- Published online August 1, 2024.
Article Versions
- Latest version (June 1, 2024 - 04:00).
- Latest version (July 15, 2024 - 03:58).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2024 by the Journal of Rheumatology This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.
Author Information
- Atul Deodhar1,
- Xenofon Baraliakos2,
- Marina Magrey3,
- Lianne S. Gensler4,
- Amit V. Thorat5⇑,
- Surya Kiran Pemmaraju6,
- Mary Jane Cadatal7 and
- Peter Nash8
- 1A. Deodhar, MD, Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, Oregon, USA;
- 2X. Baraliakos, MD, Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Bochum, Germany;
- 3M. Magrey, MD, Case Western Reserve University School of Medicine, University Hospitals, Cleveland, Ohio, USA;
- 4L.S. Gensler, MD, Department of Medicine, Division of Rheumatology, University of California at San Francisco, San Francisco, California, USA;
- 5A.V. Thorat, MD, MHA, MPharmMed, Pfizer Australia, Sydney, Australia;
- 6S.K. Pemmaraju, MSc, Pfizer, Chennai, India;
- 7M.J. Cadatal, MSc, Pfizer, Manila, Philippines;
- 8P. Nash, MBBS, Griffith University, Sunshine Coast, Nathan, Australia.
- Address correspondence to Dr. A.V. Thorat, Pfizer Australia Pty Ltd., Mezzanine Level 1, 525 Collins Street, Melbourne, Victoria 3000, Australia. Email: amitvilas.thorat{at}pfizer.com
